Cantor Fitzgerald Analysts Give Apellis Pharmaceuticals (NASDAQ:APLS) a $53.00 Price Target

Retrieved on: 2018-09-14 19:00:22

Tags for this article:

Click the tags to see associated articles and topics

Cantor Fitzgerald Analysts Give Apellis Pharmaceuticals (NASDAQ:APLS) a $53.00 Price Target. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new position in Apellis Pharmaceuticals during the first quarter worth $20,159,000. Acuta Capital Partners LLC ...</div>

Article found on:

View Original Article